Health Belief Model-Based Podcast Education for Premenstrual Symptoms in University Students (HBM-PMS-POD)

June 9, 2026 updated by: Şerife Çınar, Medipol University

Effect of a Health Belief Model-Based Podcast Education Program on Premenstrual Symptom Severity and PMS-Specific Quality of Life in University Students: A Single-Group Pretest-Posttest Quasi-Experimental Study

Premenstrual syndrome is a common women's health condition characterized by physical, psychological, and behavioral symptoms that may negatively affect daily life, academic functioning, and quality of life among young women. This study evaluated the effect of a Health Belief Model-based podcast education program on premenstrual symptom severity and PMS-specific quality of life among young female university students living in Istanbul, Türkiye.

This single-group pretest-posttest quasi-experimental study enrolled 120 participants. The intervention consisted of an eight-episode podcast education program delivered over four weeks, with two episodes per week. Premenstrual symptom severity and PMS-specific quality of life were assessed before and after the education program using validated scales.

Study Overview

Detailed Description

This study was designed as a single-group pretest-posttest quasi-experimental study to evaluate a Health Belief Model-based podcast education program for premenstrual syndrome management among university students. The study was conducted online with young female university students living in Istanbul, Türkiye.

The educational intervention was structured according to the Health Belief Model components, including perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy. The program aimed to help participants recognize PMS and PMDD symptoms, monitor their symptoms, understand the effects of PMS on quality of life and academic functioning, recognize the role of healthy lifestyle behaviors in symptom management, and develop PMS-related self-management skills.

The podcast education program lasted four weeks and included eight episodes in total. Two podcast episodes were shared each week. Each episode lasted approximately 8 to 10 minutes. Podcast episodes were shared online, and reminder messages were sent before each episode. A WhatsApp group was used to facilitate access to the podcast episodes, share educational announcements, and monitor the education process.

Data were collected using a Personal Information Form, the Premenstrual Symptoms Screening Scale, and the PMS-Specific Quality of Life Scale. The primary outcome was change in premenstrual symptom severity from baseline to posttest. The secondary outcome was change in PMS-specific quality of life from baseline to posttest.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a female university student
  • Living in Istanbul, Türkiye
  • Reporting premenstrual symptoms
  • Voluntarily agreeing to participate in the study
  • Having access to the technical resources required to follow the podcast-based education program

Exclusion Criteria:

  • Reporting a psychiatric diagnosis or receiving psychiatric treatment
  • Having previously attended an education or counseling program related to PMS
  • Studying in a directly health-related department
  • Not completing the education program
  • Not completing the posttest assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health Belief Model-Based Podcast Education Program
Participants received a Health Belief Model-based podcast education program for premenstrual syndrome management. The program was delivered online over four weeks and consisted of eight podcast episodes, with two episodes per week. Each episode lasted approximately 8 to 10 minutes.
The intervention was a structured podcast-based education program developed according to the Health Belief Model. The program included eight podcast episodes delivered over four weeks. The educational content addressed perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy in relation to PMS management. Podcast episodes were shared online, and participants were followed through a WhatsApp group for reminders and access to educational content.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Premenstrual Symptom Severity
Time Frame: Baseline and post-intervention assessment, approximately eight weeks after baseline
Premenstrual symptom severity was assessed using the Premenstrual Symptoms Screening Scale. The scale consists of 30 items and five subscales: psychological status, physical status, cognitive perception and sleep status, work and social life status, and nutritional status. Total scores range from 30 to 120, with higher scores indicating more frequent and severe premenstrual symptoms.
Baseline and post-intervention assessment, approximately eight weeks after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PMS-Specific Quality of Life
Time Frame: Baseline and post-intervention assessment, approximately eight weeks after baseline
PMS-specific quality of life was assessed using the PMS-Specific Quality of Life Scale. The scale consists of 22 items and three subscales: social well-being, emotional well-being, and physical well-being. Total scores range from 22 to 110, with higher scores indicating a greater negative impact of PMS on quality of life.
Baseline and post-intervention assessment, approximately eight weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Şerife Çınar, MSc, Medipol University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2025

Primary Completion (Actual)

April 30, 2026

Study Completion (Actual)

April 30, 2026

Study Registration Dates

First Submitted

June 9, 2026

First Submitted That Met QC Criteria

June 9, 2026

First Posted (Actual)

June 15, 2026

Study Record Updates

Last Update Posted (Actual)

June 15, 2026

Last Update Submitted That Met QC Criteria

June 9, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PMS-POD-HBM-2026
  • 1919B012554344 (Other Grant/Funding Number: TÜBİTAK 2209 University Students Research Projects Support Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be publicly shared due to participant confidentiality and ethical restrictions. De-identified data may be made available from the corresponding author upon reasonable request and subject to institutional and ethical approval.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premenstrual Syndrome

Clinical Trials on Health Belief Model-Based Podcast Education Program

Subscribe